Viewing Study NCT07275060


Ignite Creation Date: 2025-12-25 @ 2:09 AM
Ignite Modification Date: 2026-05-11 @ 4:11 AM
Study NCT ID: NCT07275060
Status: RECRUITING
Last Update Posted: 2025-12-10
First Post: 2025-11-16
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Immunogenicity and Safety of 2 Doses of Avian Influenza A (H5N1) Vaccine Administered 3 vs. 8 Weeks Apart
Sponsor: Canadian Immunization Research Network
Organization:

Organization Data

Organization:
Class: NETWORK
Study ID: CT27
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: NETWORK
Responsible Party:
Responsible Party Title:
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View
None OTHER View
None OTHER_GOV View
None OTHER View
None OTHER View
None OTHER View
None OTHER View